Home » Medical Devices » U.S. Cartilage Repair Regeneration Market

U.S. Cartilage Repair Regeneration Market

U.S Cartilage Repair Regeneration Market By Type of Cartilage (Fibrocartilage, Hyaline Cartilage, Others); By Treatment Modalities (Cell-Based Approaches, Non-Cell-Based Approaches); By Treatment Type (Palliative, Intrinsic Repair Stimulus); By Application (Knee, Spine, Ankle, Hip, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
U.S. Cartilage Repair Regeneration Market Size 2024	USD 2,330.32 million
U.S. Cartilage Repair Regeneration Market, CAGR	5.70%
U.S. Cartilage Repair Regeneration Market Size 2032	USD 3,632.21 million

Market Overview

The U.S. Cartilage Repair Regeneration Market is projected to grow from USD 2,330.32 million in 2024 to an estimated USD 3,632.21 million by 2032, with a compound annual growth rate (CAGR) of 5.70% from 2025 to 2032. This growth is attributed to the increasing prevalence of cartilage-related injuries and degenerative diseases, coupled with advancements in medical technology for cartilage regeneration.

The market drivers include an aging population, increasing incidence of sports-related injuries, and rising awareness regarding the benefits of cartilage repair treatments. Additionally, continuous research and development activities aimed at improving the effectiveness of cartilage regeneration technologies, such as stem cell therapies and tissue engineering, are fueling the market’s growth. Trends such as the increasing use of biologics and personalized treatments are expected to further bolster the market’s expansion. The growth in healthcare infrastructure and the adoption of advanced treatment options will also play a significant role in the market’s development.

Geographically, North America holds a prominent position in the cartilage repair regeneration market, with the U.S. contributing the largest share. The region benefits from a robust healthcare system, a high level of research and development, and the presence of key players in the market. Major companies such as Zimmer Biomet, Stryker Corporation, and Smith & Nephew are leading the U.S. market, offering a range of innovative cartilage repair solutions, including biologics and regenerative treatments.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The U.S. Cartilage Repair Regeneration Market is projected to grow from USD 2,330.32 million in 2024 to USD 3,632.21 million by 2032, at a CAGR of 5.70% from 2025 to 2032.
The Global Cartilage Repair Regeneration Market reached USD 5,599.25 million in 2024 and will grow at a 5.58 % CAGR to USD 8,648.13 million by 2032.
Key drivers include an aging population, rising prevalence of sports injuries, and increasing demand for advanced cartilage repair technologies like biologics and cell-based therapies.
Growing innovations in regenerative medicine, including stem cell therapies and tissue engineering, are fueling the market’s expansion.
The increasing preference for minimally invasive treatments, offering shorter recovery times, is enhancing the demand for cartilage repair solutions.
High treatment costs and regulatory challenges in the approval of new therapies may limit market growth, especially for emerging treatments.
North America, particularly the U.S., holds a prominent share of the market due to a robust healthcare system and significant investments in research and development.
Major companies like Zimmer Biomet, Stryker Corporation, and Smith & Nephew are leading the market, offering innovative cartilage repair solutions and regenerative treatments.

Report Scope

This report segments the U.S. Cartilage Repair Regeneration Market as follows:

Market Drivers

Rising Prevalence of Cartilage Injuries and Degenerative Diseases

The U.S. Cartilage Repair Regeneration Market is experiencing significant growth due to the rising prevalence of cartilage injuries and degenerative conditions such as osteoarthritis. These diseases are becoming more common with the aging population, leading to an increasing demand for effective treatments. As cartilage damage affects mobility and quality of life, there is a growing need for advanced repair and regeneration technologies. With a large number of patients seeking treatment options, the market is poised for steady expansion as healthcare providers adopt innovative solutions for cartilage repair.

For instance, recent surveys from healthcare institutions indicate that over 30 million individuals in the U.S. suffer from osteoarthritis, leading to an increasing need for cartilage repair treatments.

Advancements in Regenerative Medicine

Innovative breakthroughs in regenerative medicine are driving the U.S. Cartilage Repair Regeneration Market forward. Technologies such as stem cell therapies, gene therapies, and tissue engineering offer the potential to restore damaged cartilage and promote healing. These therapies are gaining traction due to their ability to target the underlying causes of cartilage degeneration and provide long-term benefits. As these treatments continue to evolve, they are expected to become mainstream options, further boosting market growth and transforming the way cartilage injuries are managed.

For instance, over 300 clinical trials are currently underway in the U.S. to explore regenerative medicine solutions for cartilage repair, reflecting significant innovation in the field.

Increasing Demand for Minimally Invasive Treatments

There is a rising preference for minimally invasive procedures, which is positively influencing the U.S. Cartilage Repair Regeneration Market. These procedures offer patients reduced recovery times, less pain, and lower risk of complications compared to traditional surgical methods. The growing trend towards outpatient treatments and the availability of advanced medical devices make these procedures more accessible, attracting a larger patient base. The demand for minimally invasive cartilage repair options is expected to continue increasing as patients seek efficient and convenient treatment options.

Strong Focus on Research and Development

Ongoing research and development in the field of cartilage repair is another key driver of market growth. Medical companies and research institutions in the U.S. are dedicating significant resources to exploring new techniques and technologies that can improve cartilage regeneration. This focus on innovation is expected to lead to the introduction of more advanced treatments and medical devices, further enhancing the effectiveness of cartilage repair procedures. As R\&D activities intensify, the U.S. Cartilage Repair Regeneration Market will continue to evolve, providing better outcomes for patients and expanding treatment options.

Market Trends

Shift Towards Biologics and Cell-Based Therapies

The U.S. Cartilage Repair Regeneration Market is witnessing a significant trend toward the adoption of biologics and cell-based therapies. Stem cell therapies, platelet-rich plasma (PRP) injections, and other regenerative approaches are gaining popularity due to their potential to heal damaged cartilage and promote tissue regeneration. These treatments focus on stimulating the body’s natural healing processes, offering longer-lasting solutions compared to traditional methods. As the medical community continues to explore the benefits of biologics, their application in cartilage repair is expected to grow, driving market expansion.

For instance, a clinical study conducted in 2022 by the American Academy of Orthopedic Surgeons showed that over 68,000 stem cell treatments were performed for cartilage repair in the U.S., highlighting the increasing adoption of regenerative therapies.

Growing Interest in Personalized Medicine

Personalized medicine is becoming a prominent trend in the U.S. Cartilage Repair Regeneration Market. Patients are increasingly seeking treatments tailored to their specific genetic profiles, disease severity, and overall health conditions. Advances in diagnostics and biomarker research allow healthcare providers to offer customized therapies, improving patient outcomes. This trend aligns with the broader shift towards individualized care across the healthcare sector. By offering personalized treatment options, the market can address the diverse needs of patients and enhance the effectiveness of cartilage regeneration therapies.

For instance, data from a 2023 survey by the Personalized Medicine Coalition revealed that over 150,000 patients received personalized regenerative treatments for orthopedic conditions in the U.S., demonstrating the growing interest in individualized therapies.

Market Challenges

High Treatment Costs and Accessibility Issues

One of the major challenges facing the U.S. Cartilage Repair Regeneration Market is the high cost of advanced treatments. Biologics, stem cell therapies, and other regenerative procedures are often expensive, limiting their accessibility to a wider patient base. The affordability issue is particularly challenging for uninsured or underinsured individuals, as insurance coverage for these advanced therapies remains inconsistent. This cost barrier could slow the widespread adoption of cutting-edge cartilage repair solutions, particularly in regions with lower healthcare access.

For instance, the average cost of cartilage repair procedures ranges between $18,000 and $23,000, whereas total knee replacement surgeries typically cost around $16,000

Regulatory Hurdles and Approval Delays

Another significant challenge in the U.S. Cartilage Repair Regeneration Market is the complex and lengthy regulatory approval process for new therapies and treatments. Regulatory bodies such as the FDA impose strict standards for safety and efficacy, which can delay the availability of innovative cartilage repair solutions. This often results in prolonged timeframes for market entry, limiting the ability of companies to quickly capitalize on emerging technologies. The regulatory uncertainties around new biologic and cell-based treatments further complicate the market landscape, hindering growth and innovation.

Market Opportunities

Expansion of Biologics and Regenerative Technologies

The U.S. Cartilage Repair Regeneration Market presents significant opportunities for growth through the expansion of biologics and regenerative technologies. Stem cell therapy, tissue engineering, and gene therapy offer innovative approaches to cartilage repair, addressing limitations of traditional treatments. The continued development and integration of these advanced therapies into clinical practice can greatly improve patient outcomes. Companies investing in the research and commercialization of biologic treatments are well-positioned to capitalize on the increasing demand for effective cartilage repair solutions.

Increasing Adoption of Minimally Invasive Procedures

There is a growing opportunity in the U.S. Cartilage Repair Regeneration Market with the increasing adoption of minimally invasive procedures. These treatments offer patients faster recovery times, reduced risks, and less postoperative discomfort compared to traditional surgeries. As healthcare providers focus on improving treatment accessibility and patient satisfaction, the demand for minimally invasive techniques in cartilage repair is expected to rise. This trend presents a chance for companies to develop and introduce innovative medical devices that cater to the needs of patients seeking efficient, low-risk solutions.

Market Segmentation Analysis

By Type of Cartilage

The U.S. Cartilage Repair Regeneration Market is segmented by type of cartilage into fibrocartilage, hyaline cartilage, and others. Hyaline cartilage holds a dominant share in the market due to its role in the joints, especially the knee and hip, which are most affected by degenerative conditions. Fibrocartilage, typically found in the spine and other areas, is gaining attention for its unique regenerative properties. The demand for repair solutions targeting these cartilage types is driven by the increasing prevalence of joint diseases and injuries.

By Treatment Modalities

The U.S. Cartilage Repair Regeneration Market also divides based on treatment modalities into cell-based and non-cell-based approaches. Cell-based therapies, including stem cell treatments and autologous chondrocyte implantation, have gained significant traction for their ability to promote cartilage regeneration. Non-cell-based approaches, such as microfracture and scaffolds, continue to be widely used due to their cost-effectiveness and accessibility. The growth of regenerative medicine is driving a shift towards more advanced cell-based treatments, although non-cell-based approaches maintain a strong presence in the market.

Segments

Based on Type of Cartilage

Fibrocartilage
Hyaline Cartilage
Others

Based on Treatment Modalities

Cell-Based Approaches
Non-Cell-Based Approaches

Based on Treatment Type

Palliative
Intrinsic Repair Stimulus

Based on Application

Knee
Spine
Ankle
Hip
Others

Based on Region

Northeast
Southeast
Midwest
Southwest
West

Regional Analysis

North America: The Leading Market for Cartilage Repair

The U.S. Cartilage Repair Regeneration Market is the largest and most developed market within North America. It benefits from a robust healthcare infrastructure, advanced research capabilities, and high healthcare expenditure. The presence of leading medical device companies and research institutions contributes significantly to market growth. U.S. healthcare providers are at the forefront of adopting innovative cartilage repair techniques, including biologics and regenerative therapies, which are becoming more mainstream. The aging population and the high incidence of joint-related diseases like osteoarthritis further drive the demand for advanced treatment options.

Increasing Demand for Minimally Invasive Procedures

The U.S. Cartilage Repair Regeneration Market is seeing an increasing shift towards minimally invasive procedures, particularly in major metropolitan areas. This trend is driven by patients’ preference for treatments with shorter recovery times and reduced risk of complications. Minimally invasive cartilage repair solutions, such as arthroscopic surgery and cell-based therapies, are gaining popularity due to their ability to offer effective outcomes while minimizing patient downtime. Urban areas with high healthcare access are seeing a surge in demand for these treatments, further propelling market growth in the region

Strategic Role of Key Market Players in the U.S.

The U.S. Cartilage Repair Regeneration Market is characterized by a competitive landscape, with key players such as Zimmer Biomet, Stryker Corporation, and Smith & Nephew leading the way in innovation and market share. These companies play a crucial role in the development and commercialization of cutting-edge cartilage repair solutions, including stem cell therapies, biologics, and tissue engineering. Their continued investment in research and development, as well as strategic partnerships with healthcare providers and research institutions, positions them to capitalize on the growing demand for cartilage repair treatments in the U.S.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

Arthrex
Bioventus
Orthofix Medical Inc.
DePuy Synthes
Mitek Sports Medicine

Competitive Analysis

The U.S. Cartilage Repair Regeneration Market is highly competitive, with key players actively involved in developing innovative solutions for cartilage repair. Companies like Arthrex, Bioventus, and DePuy Synthes lead in the market by offering advanced products, including cell-based therapies, biologics, and surgical instruments for cartilage regeneration. Arthrex and Mitek Sports Medicine specialize in arthroscopic procedures and sports medicine solutions, focusing on minimally invasive treatments. Bioventus and Orthofix Medical Inc. concentrate on biologic-based treatments, such as hyaluronic acid injections and platelet-rich plasma therapies, which aim to promote cartilage healing. These companies continue to invest in research and development to enhance the efficacy of their treatments. The market sees ongoing partnerships and acquisitions, positioning these players for long-term growth by expanding product portfolios and improving patient outcomes in cartilage repair.

Recent Developments

In April 2024, Zimmer Biomet and Arthrogenics entered a partnership to co-develop next-generation biologic medicines for cartilage repair, aiming to leverage Arthrogenics’ cell-therapy expertise alongside Zimmer Biomet’s orthopedic portfolio

In February 2024, the U.S. FDA granted 510(k) clearance for Zimmer Biomet’s ROSA Shoulder System, the first robotic-assisted solution cleared for total and reversshoulder arthroplasty, signaling enhanced precision in joint restoration procedures.

In June 2024, Askel Healthcare Ltd presented first clinical-trial results of its COPLA knee cartilage implant at the 9th Joint Preservation Congress in Warsaw, demonstrating early safety and functional gains in focal cartilage repair.

On September 17, 2024, Sparta Biomedical announced treatment of the first patients with its Ormi™ partial-knee resurfacing device, a biomimetic implant designed to restore cartilage function and slow osteoarthritis progression.

On December 18, 2024, Mesoblast’s Ryoncil (remestemcel-L) received U.S. FDA approval as the first mesenchymal stromal cell therapy for pediatric steroid-refractory acute graft-versus-host disease, paving the way for broader MSC applications—including potential off-label exploration in cartilage repair contexts.

On May 8, 2025, Smith + Nephew published 4-year follow-up data showing that patients treated with its CARTIHEAL™ AGILI-C™ implant experienced an 87% lower risk of eventual knee arthroplasty or osteotomy, underscoring long-term implant durability and functional improvement

In February 2025, Mesoblast reported financial and operational results confirming advancement of its proprietary mesenchymal-cell platform; the report noted ongoing preparation for pivotal trials in orthopedic indications, including chronic low back pain and osteoarthritis models.

Market Concentration and Characteristics

The U.S. Cartilage Repair Regeneration Market is characterized by moderate concentration, with a few dominant players leading the development and commercialization of cartilage repair solutions. Key companies such as Arthrex, Bioventus, and DePuy Synthes hold significant market shares, driving innovation and competitive dynamics in the market. The market features a blend of large multinational corporations and specialized companies focusing on biologics, cell-based therapies, and minimally invasive surgical techniques. The presence of a diverse range of treatment options, including non-cell-based and cell-based approaches, contributes to its competitive nature. Market growth is supported by technological advancements and strong research and development efforts, which continue to shape the landscape. Companies are increasingly focusing on expanding their product portfolios and forming strategic alliances to strengthen their positions and meet the rising demand for effective cartilage regeneration treatments.

Report Coverage

The research report offers an in-depth analysis based on Type of Cartilage, Treatment Modalities, Treatment Type, Application and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The U.S. Cartilage Repair Regeneration Market is expected to experience sustained growth driven by the increasing demand for advanced cartilage repair solutions. The market will continue to expand with new product launches and technological advancements.

The growing adoption of biologics and stem cell therapies is anticipated to drive innovation in cartilage repair treatments. These approaches will offer patients more effective and long-lasting solutions to cartilage degeneration.

Minimally invasive procedures will become more prevalent, offering patients quicker recovery times and reduced risk of complications. This shift will help expand treatment accessibility and improve overall patient outcomes.

Personalized treatments tailored to the individual’s specific needs will become a major trend in cartilage repair. Advances in diagnostic technologies will enable more customized and effective therapies for patients.

Growing awareness of cartilage repair options will lead to higher patient demand, particularly among those with joint issues and degenerative diseases. This will contribute to market growth as more individuals seek treatment.

The increasing prevalence of osteoarthritis and sports-related injuries will drive the need for cartilage regeneration solutions. This trend will continue to support the demand for innovative treatment options in the market.

Cell-based therapies, including autologous chondrocyte implantation and stem cell injections, will gain broader adoption. These therapies will provide patients with more effective and less invasive alternatives for cartilage repair.

With increasing regulatory support for regenerative medicine, the approval of new cartilage repair treatments will become faster. This will accelerate the introduction of innovative solutions to the market.

Innovations in treatment delivery methods, including advanced implants and biomaterials, will enhance the effectiveness of cartilage repair. These technologies will improve patient outcomes and drive further market growth.

Leading companies in the U.S. Cartilage Repair Regeneration Market will form strategic collaborations with healthcare providers and research institutions. These partnerships will fuel the development of new therapies and expand market reach.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Type of Cartilages 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. U.S. Cartilage Repair Regeneration Market Snapshot 21

2.1.1. U.S. Cartilage Repair Regeneration Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : U.S. CARTILAGE REPAIR REGENERATION MARKET – INDUSTRY ANALYSIS 23

3.1. Introduction 23

3.2. Market Drivers 24

3.2.1. Surge in Sports Injuries Among Youth and Professional Athletes 24

3.2.2. Expansion of Outpatient Orthopedic Surgery Centers 25

3.3. Market Restraints 26

3.3.1. Complexity in Conducting Multicenter Clinical Trials 26

3.4. Market Opportunities 27

3.4.1. Market Opportunity Analysis 27

3.5. Porter’s Five Forces Analysis 28

CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 29

4.1. Company Market Share Analysis – 2024 29

4.1.1. U.S. Cartilage Repair Regeneration Market: Company Market Share, by Revenue, 2024 29

4.1.2. U.S. Cartilage Repair Regeneration Market: Top 6 Company Market Share, by Revenue, 2024 29

4.1.3. U.S. Cartilage Repair Regeneration Market: Top 3 Company Market Share, by Revenue, 2024 30

4.2. U.S. Cartilage Repair Regeneration Market Company Revenue Market Share, 2024 31

4.3. Company Assessment Metrics, 2024 32

4.3.1. Stars 32

4.3.2. Emerging Leaders 32

4.3.3. Pervasive Players 32

4.3.4. Participants 32

4.4. Start-ups /SMEs Assessment Metrics, 2024 32

4.4.1. Progressive Companies 32

4.4.2. Responsive Companies 32

4.4.3. Dynamic Companies 32

4.4.4. Starting Blocks 32

4.5. Strategic Developments 33

4.5.1. Acquisitions & Mergers 33

New Product Launch 33

U.S. Expansion 33

4.6. Key Players Product Matrix 34

CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 35

5.1. PESTEL 35

5.1.1. Political Factors 35

5.1.2. Economic Factors 35

5.1.3. Social Factors 35

5.1.4. Technological Factors 35

5.1.5. Environmental Factors 35

5.1.6. Legal Factors 35

5.2. Adjacent Market Analysis 35

CHAPTER NO. 6 : U.S. CARTILAGE REPAIR REGENERATION MARKET – BY TYPE OF CARTILAGE SEGMENT ANALYSIS 36

6.1. U.S. Cartilage Repair Regeneration Market Overview, by Type of Cartilage Segment 36

6.1.1. U.S. Cartilage Repair Regeneration Market Revenue Share, By Type of Cartilage, 2023 & 2032 37

6.1.2. U.S. Cartilage Repair Regeneration Market Attractiveness Analysis, By Type of Cartilage 38

6.1.3. Incremental Revenue Growth Opportunity, by Type of Cartilage, 2024 – 2032 38

6.1.4. U.S. Cartilage Repair Regeneration Market Revenue, By Type of Cartilage, 2018, 2023, 2027 & 2032 39

6.2. Fibrocartilage 40

6.3. Hyaline Cartilage 41

6.4. Others 42

CHAPTER NO. 7 : U.S. CARTILAGE REPAIR REGENERATION MARKET – BY TREATMENT MODALITIES SEGMENT ANALYSIS 43

7.1. U.S. Cartilage Repair Regeneration Market Overview, by Treatment Modalities Segment 43

7.1.1. U.S. Cartilage Repair Regeneration Market Revenue Share, By Treatment Modalities, 2023 & 2032 44

7.1.2. U.S. Cartilage Repair Regeneration Market Attractiveness Analysis, By Treatment Modalities 45

7.1.3. Incremental Revenue Growth Opportunity, by Treatment Modalities, 2024 – 2032 45

7.1.4. U.S. Cartilage Repair Regeneration Market Revenue, By Treatment Modalities, 2018, 2023, 2027 & 2032 46

7.2. Cell-Based Approaches 47

7.3. Non-Cell-Based Approaches 48

CHAPTER NO. 8 : U.S. CARTILAGE REPAIR REGENERATION MARKET – BY TREATMENT TYPE SEGMENT ANALYSIS 49

8.1. U.S. Cartilage Repair Regeneration Market Overview, by Treatment Type Segment 49

8.1.1. U.S. Cartilage Repair Regeneration Market Revenue Share, By Treatment Type, 2023 & 2032 50

8.1.2. U.S. Cartilage Repair Regeneration Market Attractiveness Analysis, By Treatment Type 51

8.1.3. Incremental Revenue Growth Opportunity, by Treatment Type, 2024 – 2032 51

8.1.4. U.S. Cartilage Repair Regeneration Market Revenue, By Treatment Type, 2018, 2023, 2027 & 2032 52

8.2. Palliative 53

8.3. Intrinsic Repair Stimulus 54

CHAPTER NO. 9 : U.S. CARTILAGE REPAIR REGENERATION MARKET – BY APPLICATION SEGMENT ANALYSIS 55

9.1. U.S. Cartilage Repair Regeneration Market Overview, by Application Segment 55

9.1.1. U.S. Cartilage Repair Regeneration Market Revenue Share, By Application, 2023 & 2032 56

9.1.2. U.S. Cartilage Repair Regeneration Market Attractiveness Analysis, By Application 57

9.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 57

9.1.4. U.S. Cartilage Repair Regeneration Market Revenue, By Application, 2018, 2023, 2027 & 2032 58

9.2. Knee 59

9.3. Spine 60

9.4. Ankle 61

9.5. Hip 62

9.6. Others 63

CHAPTER NO. 10 : U.S. CARTILAGE REPAIR REGENERATION MARKET – ANALYSIS 64

10.1. Type of Cartilage 64

10.1.1. U.S. Cartilage Repair Regeneration Market Revenue, By Type of Cartilage, 2018 – 2023 (USD Million) 64

10.1.2. U.S. Cartilage Repair Regeneration Market Revenue, By Type, 2024 – 2032 (USD Million) 64

10.2. Treatment Modalities 65

10.2.1. U.S. Cartilage Repair Regeneration Market Revenue, By Treatment Modalities, 2018 – 2023 (USD Million) 65

10.2.2. U.S. Cartilage Repair Regeneration Market Revenue, By Treatment Modalities, 2024 – 2032 (USD Million) 65

10.3. Treatment Type 66

10.3.1. U.S. Cartilage Repair Regeneration Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 66

10.3.2. U.S. Cartilage Repair Regeneration Market Revenue, By Treatment Type, 2024 – 2032 (USD Million) 66

10.4. Application 67

10.4.1. U.S. Cartilage Repair Regeneration Market Revenue, By Application, 2018 – 2023 (USD Million) 67

10.4.2. U.S. Cartilage Repair Regeneration Market Revenue, By Application, 2024 – 2032 (USD Million) 67

CHAPTER NO. 11 : COMPANY PROFILES 68

11.1. Arthrex 68

11.1.1. Company Overview 68

11.1.2. Product Portfolio 68

11.1.3. Swot Analysis 68

11.1.4. Business Strategy 69

11.1.5. Financial Overview 69

11.2. Bioventus 70

11.3. Orthofix Medical Inc. 70

11.4. DePuy Synthes 70

11.5. Mitek Sports Medicine 70

11.6. Company 6 70

11.7. Company 7 70

11.8. Company 8 70

11.9. Company 9 70

11.10. Company 10 70

List of Figures

FIG NO. 1. U.S. Cartilage Repair Regeneration Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for U.S. Cartilage Repair Regeneration Market 28

FIG NO. 3. Company Share Analysis, 2024 29

FIG NO. 4. Company Share Analysis, 2024 29

FIG NO. 5. Company Share Analysis, 2024 30

FIG NO. 6. U.S. Cartilage Repair Regeneration Market – Company Revenue Market Share, 2024 31

FIG NO. 7. U.S. Cartilage Repair Regeneration Market Revenue Share, By Type of Cartilage, 2023 & 2032 37

FIG NO. 8. Market Attractiveness Analysis, By Type of Cartilage 38

FIG NO. 9. Incremental Revenue Growth Opportunity by Type of Cartilage, 2024 – 2032 38

FIG NO. 10. U.S. Cartilage Repair Regeneration Market Revenue, By Type of Cartilage, 2018, 2023, 2027 & 2032 39

FIG NO. 11. U.S. Cartilage Repair Regeneration Market for Fibrocartilage, Revenue (USD Million) 2018 – 2032 40

FIG NO. 12. U.S. Cartilage Repair Regeneration Market for Hyaline Cartilage, Revenue (USD Million) 2018 – 2032 41

FIG NO. 13. U.S. Cartilage Repair Regeneration Market for Others, Revenue (USD Million) 2018 – 2032 42

FIG NO. 14. U.S. Cartilage Repair Regeneration Market Revenue Share, By Treatment Modalities, 2023 & 2032 44

FIG NO. 15. Market Attractiveness Analysis, By Treatment Modalities 45

FIG NO. 16. Incremental Revenue Growth Opportunity by Treatment Modalities, 2024 – 2032 45

FIG NO. 17. U.S. Cartilage Repair Regeneration Market Revenue, By Treatment Modalities, 2018, 2023, 2027 & 2032 46

FIG NO. 18. U.S. Cartilage Repair Regeneration Market for Cell-Based Approaches, Revenue (USD Million) 2018 – 2032 47

FIG NO. 19. U.S. Cartilage Repair Regeneration Market for Non-Cell-Based Approaches, Revenue (USD Million) 2018 – 2032 48

FIG NO. 20. U.S. Cartilage Repair Regeneration Market Revenue Share, By Treatment Type, 2023 & 2032 50

FIG NO. 21. Market Attractiveness Analysis, By Treatment Type 51

FIG NO. 22. Incremental Revenue Growth Opportunity by Treatment Type, 2024 – 2032 51

FIG NO. 23. U.S. Cartilage Repair Regeneration Market Revenue, By Treatment Type, 2018, 2023, 2027 & 2032 52

FIG NO. 24. U.S. Cartilage Repair Regeneration Market for Palliative, Revenue (USD Million) 2018 – 2032 53

FIG NO. 25. U.S. Cartilage Repair Regeneration Market for Intrinsic Repair Stimulus, Revenue (USD Million) 2018 – 2032 54

FIG NO. 26. U.S. Cartilage Repair Regeneration Market Revenue Share, By Application, 2023 & 2032 56

FIG NO. 27. Market Attractiveness Analysis, By Application 57

FIG NO. 28. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 57

FIG NO. 29. U.S. Cartilage Repair Regeneration Market Revenue, By Application, 2018, 2023, 2027 & 2032 58

FIG NO. 30. U.S. Cartilage Repair Regeneration Market for Knee, Revenue (USD Million) 2018 – 2032 59

FIG NO. 31. U.S. Cartilage Repair Regeneration Market for Spine, Revenue (USD Million) 2018 – 2032 60

FIG NO. 32. U.S. Cartilage Repair Regeneration Market for Ankle, Revenue (USD Million) 2018 – 2032 61

FIG NO. 33. U.S. Cartilage Repair Regeneration Market for Hip, Revenue (USD Million) 2018 – 2032 62

FIG NO. 34. U.S. Cartilage Repair Regeneration Market for Others, Revenue (USD Million) 2018 – 2032 63

List of Tables

TABLE NO. 1. : U.S. Cartilage Repair Regeneration Market: Snapshot 21

TABLE NO. 2. : Drivers for the U.S. Cartilage Repair Regeneration Market: Impact Analysis 24

TABLE NO. 3. : Restraints for the U.S. Cartilage Repair Regeneration Market: Impact Analysis 26

TABLE NO. 4. : U.S. Cartilage Repair Regeneration Market Revenue, By Type of Cartilage, 2018 – 2023 (USD Million) 64

TABLE NO. 5. : U.S. Cartilage Repair Regeneration Market Revenue, By Type of Cartilage, 2024 – 2032 (USD Million) 64

TABLE NO. 6. : U.S. Cartilage Repair Regeneration Market Revenue, By Treatment Modalities, 2018 – 2023 (USD Million) 65

TABLE NO. 7. : U.S. Cartilage Repair Regeneration Market Revenue, By Treatment Modalities, 2024 – 2032 (USD Million) 65

TABLE NO. 8. : U.S. Cartilage Repair Regeneration Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 66

TABLE NO. 9. : U.S. Cartilage Repair Regeneration Market Revenue, By Treatment Type, 2024 – 2032 (USD Million) 66

TABLE NO. 10. : U.S. Cartilage Repair Regeneration Market Revenue, By Application, 2018 – 2023 (USD Million) 67

TABLE NO. 11. : U.S. Cartilage Repair Regeneration Market Revenue, By Application, 2024 – 2032 (USD Million) 67

Frequently Asked Questions

What is the projected market size of the U.S. Cartilage Repair Regeneration Market in 2023, 2032, and its CAGR?

The U.S. Cartilage Repair Regeneration Market is expected to reach USD 2,330.32 million in 2024 and grow to USD 3,632.21 million by 2032, with a CAGR of 5.70% from 2025 to 2032.

What are the main drivers of the U.S. Cartilage Repair Regeneration Market?

The market growth is driven by an aging population, increasing sports injuries, and rising awareness of cartilage repair treatments, along with technological advancements in regenerative medicine.

How does the healthcare system in the U.S. contribute to the market?

The robust healthcare system in the U.S. supports the growth of the Cartilage Repair Regeneration Market through high-quality research and development, along with a wide range of treatment options.

Which companies are leading the U.S. Cartilage Repair Regeneration Market?

Key players like Zimmer Biomet, Stryker Corporation, and Smith & Nephew are leading the U.S. market, offering advanced regenerative solutions and biologic therapies for cartilage repair

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Reviewed By
Gunakesh Parmar

Research Consultant

With over 15 years of dedicated experience in market research since 2009, specializes in delivering actionable insights from data.

View Profile

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$8699

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –